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Abstract 
Introduction. Adenosine is taken up via human equilibrative nucleoside transporters 1 30 
(hENT1) and 2 (hENT2) at a physiological extracellular pH (pHo ∼7.4) in human umbilical 
vein endothelial cells (HUVECs). Acidic pHo increases the uptake of adenosine and 5-
hydroxytryptamine (5HT) via hENT4 in this cell type. However, modulation of hENT1 and 
hENT2 transport activity by the pHi is unknown. We investigated whether hENT1 and 
hENT2-adenosine transport was regulated by acidic pHi.  35 
Methods. HUVECs loaded with a pH sensitive probe were subjected to 0.1-20 mmol/L NH4Cl 
pulse assay to generate 6.9-6.2 pHi. Before pHi started to recover, adenosine transport kinetics 
(0-500 µmol/L, 37ºC) in the absence or presence 1 or 10 µmol/L S-(4-nitrobenzyl)-6-thio-
inosine (NBTI), 2 mmol/L hypoxanthine,  2 mmol/L adenine, 100 µmol/L 5HT, or 500 
µmol/L adenosine, was measured.  40 
Results. Overall adenosine transport (i.e., hENT1+hENT2) was semisaturable and partially 
inhibited by 1 µmol/L, but abolished by 10 µmol/L NBTI in cells non-treated or treated with 
NH4Cl. The initial velocity and non-saturable, lineal component for overall transport were 
increased after NH4Cl pulse. hENT1 and hENT2-mediated adenosine transport maximal 
capacity was increased by acidic pHi. hENT1 activity was more sensitive than hENT2 activity 45 
to acidic pHi. 
Discussion. hENT1 and hENT2-adenosine transport is differentially regulated by acidic pHi in 
HUVECs. These findings are important in pathologies associated with pHi alterations such as 
gestational diabetes mellitus. 
 50 
Keywords: adenosine transport; intracellular pH; ENT transporters; endothelium; foetus 
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1. Introduction 
 The maintenance of a physiological intracellular (pHi) and extracellular (pHo) pH is 
under light modulation by plasma membrane transport mechanisms that remove protons (H+) 55 
to the extracellular space [1-3]. These phenomena include the sodium (Na+)/H+ exchanger 1 
(NHE1) as the primary regulator of the pHi/pHo ratio. Uptake of metabolic substrates happens 
via different membrane transport systems in adult and foetoplacental endothelium [4,5]. Some 
of these transport systems depend on the pHo, such as those mediating adenosine and 5-
hydroxytryptamine (5HT) [6]. The endogenous nucleoside adenosine is reported to increase 60 
the L-arginine transport and synthesis of nitric oxide (NO) in the human foetoplacental micro 
and macrovascular endothelium from normal or pathological pregnancies such as gestational 
diabetes mellitus (GDM) [7-10]. This phenomenon results from activation of adenosine 
receptors due to the extracellular accumulation of this nucleoside arising from a reduced 
uptake by the foetoplacental endothelium [8,10,11]. Thus, a proper function of membrane 65 
transport mechanisms modulating the extracellular concentration of adenosine is critical to 
mantaining the physiological cell metabolism in this vascular bed [4,8-10] as in other tissues 
[5,6]. 
 Adenosine nucleoside is taken up via the human equilibrative nucleoside transporters 
(hENTs) in the human umbilical vein (HUVECs) [11] and placental microvascular (hPMECs) 70 
[12] endothelial cells. hENTs corresponds to a family of at least four proteins, i.e., hENT1, 
hENT2, hENT3, and hENT4. hENT1 and hENT2 mediate adenosine uptake in HUVECs from 
normal or pathological pregnancies, including GDM [11]. Despite the proposed activation of 
hENT4-mediated adenosine and 5HT transport in response to an acidic pHo in HUVECs [6], 
the role of a change in pHi or pHo regulating hENT1 and hENT2 transport activity in this or 75 
other cell type is unknown [3,5]. One study shows that an acidic pHi increases adenosine 
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efflux in perfused rat skeletal muscle [13], but not an attempt to address the type(s) of 
membrane transporters involved in this phenomenon was given. Additionally, pre-gestational 
diabetes mellitus associated with acidic pH (pH <7.2) in the umbilical vein blood [14]. Since 
GDM also associates with lower hENT1 and hENT2-mediated adenosine transport in 80 
HUVECs [11] and hPMECs [12], we hypothesize that adenosine transport mediated via 
hENT1 and hENT2 is under regulation by an acidic pHi in HUVECs.  
 
2. Materials and methods 
 See the expanded Methods section in the online Supplementary material. 85 
 
2.1. Umbilical cords and cell culture  
  Human placentas were collected after delivery from 31 full-term normal pregnancies 
from the Hospital Clínico UC-CHRISTUS in Santiago de Chile (investigation conforms to the 
Declaration of Helsinki, and counts with Ethics Committee approval from the Faculty of 90 
Medicine of the Pontificia Universidad Católica de Chile and informed consent of patients). 
Sections of umbilical cords were transferred into 200 mL phosphate-buffered saline (PBS) 
solution ((mmol/L): 130 NaCl, 2.7 KCl, 0.8 Na2HPO4, 1.4 KH2PO4 (pH 7.4, 4ºC)) to the 
laboratory.  
 Human umbilical vein endothelial cells (HUVECs) were isolated by digestion with 95 
collagenase from umbilical cord veins and cultured (5% O2, 5% CO2, 37°C) in primary culture 
medium (PCM: medium 199 (M199, Gibco Life Technologies, Carlsbad, CA, USA), 5 
mmol/L D-glucose, 10% new born calf serum, 10% foetal calf serum (Gibco), 3.2 mmol/L L-
glutamine, 100 U/mL penicillin-streptomycin (Gibco)) as described [10,15]. Experiments were 
in primary cultured cells in passage 3 in the absence or presence of 1 or 10 µmol/L S-(4-100 
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nitrobenzyl)-6-thio-inosine (NBTI) (Sigma, Atlanta, GA, USA), inhibitory concentrations for 
hENT1 or hENT1+hENT2 transport, respectively, 2 mmol/L hypoxanthine, and 2 mmol/L 
adenine (nucleobases taken up via ENT2) [11]. Parallel experiments were in the presence of 
100 µmol/L 5-hydroxytryptamine (5HT, an amine that is taken up via ENT4 at pHo ~5.5) [6] 
or 500 µmol/L adenosine. Cell viability was assayed using 3-(4,5-dimethylthiazol-2-yl)-2,5-105 
diphenyltetra-zolium bromide assay (Sigma-Aldrich) as reported [16].  
 
2.2. pHi measurement and recovery  
 Cells were loaded (10 minutes, 37°C) with the fluorescent pH sensitive probe 2,7-
bicarboxyethyl-5,6-carboxyfluorescein acetoxymethyl ester (BCECF-AM, 12 µmol/L) 110 
(Sigma-Aldrich) as described [16-18]. Probe excess was removed rinsing (x3) with control 
solution (CS) ((mmol/L) NaCl 145, KCl 5, NaH2PO4 1 Na2SO4 1, CaCl2 1.8, MgCl2 1, HEPES 
30, D-glucose 5 (pH 7.4, 37ºC)). Fluorescence ratios were registered every 2 seconds interval 
(150 seconds). The pHi was estimated using standard calibration curves with 10 µmol/L 
nigericin in calibrating solution (pH 6.2, 7.2, 8.2) as described [16-18]. The pHi recovery was 115 
examined by the NH4Cl pulse technique [16-18]. After the basal pHi was stabilized (∼3 
minutes) cells were exposed (2 minutes) to CS with 0.1, 1, or 20 mmol/L NH4Cl (NH4Cl/CS 
solution). Cells were then rinsed with NH4Cl-free CS (for media composition see online 
Supplemental Methods) and cell viability assayed as above.  
 120 
2.3. Transport assays 
 Since pHi recovery started after 15 seconds of removal of NH4Cl/CS, transport assays 
in CS were at 10 seconds (37ºC). The difference between total 2,3-[3H]adenosine uptake 
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(NEN, Dreieich, FRG) in the absence or presence of 1 µmol/L NBTI was ENT1-mediated 
adenosine transport. The difference between adenosine uptake in the presence of 1 and 10 125 
µmol/L NBTI, 2 mmol/L hypoxanthine, or 2 mmol/L adenine was hENT2-mediated adenosine 
transport [11,15]. Overall 100 µmol/L [3H]hypoxanthine (NEN) was also measured as 
described for adenosine. Initial rate (vi) for overall transport, maximal velocity (Vmax) and 
apparent Michaelis-Menten constant (Km) of saturable transport was determined as reported 
[11,12]. The relative contribution of hENT1 and hENT2 (hENT1/2F) to total transport in cells 130 
non-treated (–NH4) or treated (+NH4) with NH4Cl was estimated from Vmax/Km, and the 
relative effect of NH4Cl on transport activity via hENT1 (1/-NH4/+NH4FhENT1) or hENT2 (1/-
NH4/+NH4FhENT2) was estimated (see Supplemental Methods). 
 
2.4. Western blotting 135 
 Total protein samples separated via polyacrylamide gel electrophoresis were probed 
with a primary polyclonal goat anti-hENT1 (1:1000) or anti-hENT2 (1:1000) (Santa Cruz 
Biotechnology, USA), or monoclonal mouse anti-ß-actin (1:3000) (Sigma Aldrich, St Louis, 
MO, USA) antibody, followed by incubation (1 hour) in Tris buffer saline Tween/0.2% bovine 
serum albumin containing secondary horseradish peroxidase conjugated goat anti-goat or anti-140 
mouse antibodies (Santa Cruz Biotechnology) as described [11,12]. Proteins were detected by 
enhanced chemiluminescence in a ChemiDoc-It 510 Imagen System (UVP, LCC Upland, CA, 
USA) and quantified by densitometry [11,12]. 
 
2.5. Statistics 145 
Values are mean ± SEM, where n indicates the number of different cell cultures (3-4 
replicates) from various pregnant women. Comparisons between two and more groups were 
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performed by Student’s unpaired t-test and analysis of variance (2-ways ANOVA), 
respectively. P<0.05 was considered statistically significant. 
 150 
3. Results 
3.1. Basal pHi  
 The basal pHi value (7.21 ± 0.04) (Fig. 1A) was lower in cells exposed to NH4Cl in a 
concentration-dependent manner, without altering the cell survival (Fig. 1B). NH4Cl increased 
the pHi value (Fig. 1C), and NH4Cl removal caused rapid acidification (~1 second) recovering 155 
to initial pHi value in ~7 minutes. Intracellular acidification was for 15 seconds before a 
significant pHi recovery (Fig. 1D).  
 
3.2. NH4Cl effect on adenosine uptake 
 Overall adenosine uptake was equally inhibited by adenosine or 1 µmol/L NBTI in the 160 
absence of NH4Cl (Fig. 2A). Hypoxanthine and adenine caused a minor inhibition unaltered 
by these molecules. Adenosine uptake was also inhibited by 10 µmol/L NBTI in a higher 
proportion than 1 µmol/L NBTI. The fraction of uptake inhibited by 10 versus 1 µmol/L NBTI 
(0.051 ± 0.01 pmol/µg protein/second) was similar to the inhibition by hypoxanthine, adenine, 
or hypoxanthine + adenine. Hypoxanthine + adenine + adenosine caused the larger inhibition 165 
(0.187 ± 0.021 pmol/µg protein/second) and was similar to the added individual inhibitions 
caused by these molecules alone.  
 The challenge with 1 mmol/L NH4Cl increased overall adenosine transport (Fig. 2A). 
A higher inhibition of 1 µmol/L NBTI and adenosine was seen compared with cells in the 
absence of NH4Cl. Adenosine uptake was further reduced by 10 µmol/L NBTI.  The inhibition 170 
caused by 10 versus 1 µmol/L NBTI (0.063 ± 0.008 pmol/µg protein/second) was similar to 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 
8
the inhibition by hypoxanthine, adenine, or hypoxanthine + adenine. hENT1-adenosine uptake 
was higher than hENT2-mediated uptake in cells non-treated or treated with NH4Cl (Fig. 2B). 
Incubation with 1 mmol/L NH4Cl increased hENT1- and hENT2-adenosine transport; 
however, the increase in hENT1- was higher than hENT2-mediated transport. Incubation of 175 
cells with 5HT unaltered adenosine uptake. 
 Hypoxanthine uptake was inhibited by 10 µmol/L NBTI with or without adenine or 
5HT, but increased by NH4Cl (Fig. 2C). hENT2-hypoxanthine uptake was higher than 
hENT1-uptake in cells non-treated or treated with NH4Cl (Fig. 2D). NH4Cl increased only 
hENT2-hypoxanthine uptake.  180 
 
3.3. pHi-dependent adenosine uptake 
 Overall adenosine uptake was higher in cells incubated with NH4Cl in a concentration-
dependent manner (Fig. 3A). NBTI inhibited uptake was greater as NH4Cl concentration 
increased. hENT1- and hENT2-adenosine uptake increased with NH4Cl (Fig. 3B) with similar 185 
EC50 values (EC50 = 1.2 ± 0.3 and 1.3 ± 0.3 mmol/L NH4Cl for hENT1 and hENT2, 
respectively) and comparable to overall transport (EC50 = 1.2 ± 0.2 mmol/L NH4Cl). hENT1- 
and hENT2-adenosine uptake increased by acidic pHi values (Fig. 3C). Equally, the slope of 
hENT1 and hENT2-mediated uptake increase as the pHi was lower, and slope of pHi effect 
was higher for hENT1- compared with hENT2-adenosine uptake (-0.298 ± 0.029 versus -190 
0.081 ± 0.031 pmol/µg protein/second/(pHi unit)). The NH4Cl-increased slope and adenosine 
uptake via hENT2 were less pronounced than these parameters for hENT1-mediated transport. 
Parallel experiments show that protein abundance for hENT1 was higher (2.5 ± 0.2 fold) than 
hENT2 in HUVECs (Fig. 3D), confirming previous observations in this cell type [11,15]. 
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 195 
3.4. pHi-dependent hENT1 and hENT2 transport kinetics 
 Overall adenosine transport was semisaturable and partially inhibited by 1, but 
abolished by 10 µmol/L NBTI (Fig. 4A). The vi and KD for overall transport were higher in 
NH4Cl treated compared with non-treated cells (Table 1). The KD was reduced by 1 µmol/L 
NBTI to similar values in NH4Cl treated and non-treated cells. Eadie-Hofstee plot for overall 200 
transport was biphasic, except in the presence of 10 µmol/L NBTI. 
 Saturable adenosine transport via hENT1 (Fig. 4B) and hENT2 (Fig. 4C) were 
saturable, adjusted to a single Michaelis-Menten equation, with linear Eadie-Hofstee plots. 
NH4Cl increased the Vmax and apparent Km for saturable transport (Table 1). The Vmax/Km was 
higher in NH4Cl-treated cells for both membrane transporters types. The relative contribution 205 
of NH4Cl to a change in the Vmax/Km for adenosine transport was higher for hENT1 compared 
with hENT2-mediated.   
 
4. Discussion 
  This study shows that EN s activity in HUVECs is under regulation by the pHi. 210 
Intracellular acidification increases adenosine transport with hENT1 being more sensitive to 
pHi than hENT2-mediated transport. Increase transport shows with higher maximal adenosine 
transport capacity (Vmax/Km) in HUVECs. This phenomenon could be crucial to maintaining 
the extracellular concentration of adenosine thus regulating its broad biological effects with 
implications in diseases associated with dysregulation of hENTs activity, such as GDM and 215 
cancer, where pHo [11,12] and pHi [17] are altered.    
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 Primary cultured HUVECs show a pHi ∼7.2 when exposed to pHo ∼7.4, suggesting 
adequate pHi modulation under physiological conditions. The pHi in HUVECs was similar 
[19-22] or slightly lower [23] to previous reports in this cell type, but close to pH in the human 
umbilical vein blood (pH ∼7.35) [14,24,25]. Thus, pHi modulation in foetal endothelium is 220 
tunned with pHo changes (see review [3]). Lower pHi value is observed in lymphoblasts 
incubated with 25 mmol/L D-glucose likely due to activated NHE1 [25]. NHE1 is an isoform 
of NHE’s membrane transporters playing a significant role in the regulation of pHi [1-3]. It 
was reported that a delay in pHi recovery after intracellular acidosis reduces endothelial cell 
activation [21] probably due to lower activation of NHE1 and V-type H+ ATPases [26,27]. 225 
Thus, an acidic intracellular medium results in modulation of plasma membrane transporters 
activity.  
hENT1 and hENT2 isoforms of the SLC29A family members mediates adenosine 
uptake under a physiological pHo (pHo ∼7.4) in HUVECs [11]. hENT1 protein abundance is 
higher than hENT2 protein abundance under these conditions, confirming previous results in 230 
HUVECs [11,15]. Also, the relative contribution of hENT1 to adenosine transport (hENT1/2F
–
NH4) was ∼5.5 fold than for hENT2 mediated adenosine transport. HUVECs also expresses 
hENT4, an isoform with nucleoside and 5HT transport activity increased at pHo ∼5.0-6.5, but 
not functional for adenosine uptake at pHo >7.0 [6]. Since changes in pHo results in 
modulation of pHi, as described in neonatal rat carotid body type-I cells [28], increased 235 
hENT4 activity reported in HUVECs could be a response to pHi acidification. However, the 
latter is unlikely since an extracellular alkalization increased the pHi, but extracellular 
acidification did not alter pHi in rat aorta endothelial cells [29]. Our results show that overall 
adenosine uptake in HUVECs is increased by intracellular acidification with a preferential 
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activation of the maximal transport capacity via hENT1 compared with hENT2 ((1/–240 
NH4/+NH4FhENT1)/(1/–NH4/+NH4FhENT2) ∼1.15). Since EC50 values for NH4Cl-reduced pHi were 
comparable to NH4Cl-increased overall and hENT1 or hENT2-transport, a positive correlation 
between intracellular acidification and increased adenosine transport is likely in HUVECs. 
The latter was confirmed by results showing higher slope (∼3.7 fold) of hENT1 compared 
with hENT2-adenosine transport. Since NH4Cl pulse also increased hENT2-, but not hENT1-245 
hypoxanthine uptake, and was unaltered by 5HT, hENT2 is under modulation of acidic pHi in 
HUVECs.   
The acidic pHi-dependent increase in hENT1 transport activity is seen from a reduction 
in 0.3 pHi units; a phenomenon maintained up to a change in 1 pHi unit. Interestingly, a 
decrease in ∼0.5 pHi units increases adenosine efflux in perfused rat soleus muscle fibers [13]. 250 
Since ENTs-adenosine transport is bidirectional down its concentration gradient, similar 
kinetics properties (i.e., apparent affinity (1/Km), Vmax, or Vmax/Km) for influx and efflux are 
likely [5]. Additionally, the acidic pHi-dependent increase in ENTs-adenosine transport is not 
exclusive for HUVECs. The possibility that adenosine uptake at pHi 6.0-6.5 was mediated by 
activation of hENT4 in HUVECs is unlikely since 5HT, which is taken up by hENT4 [6], did 255 
not alter overall, hENT1, and hENT2 transport.  
 Overall adenosine transport (up to 500 µmol/L adenosine) was mediated by a saturable 
plus a linear, non-saturable component working in parallel, as reported for adenosine [11,15] 
and other substrates [17,30] and cell types [30-32]. This phenomenon was reflected in a non-
linear, biphasic representation of the Eadie-Hofstee plots of overall data. The latter meaning 260 
that two or more membrane transport mechanisms with similar kinetics transport parameters 
or availability at the plasma membrane [31,32] is likely. Indeed, Km values for hENT1- and 
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hENT2-mediated transport were similar in HUVECs non-treated or treated with NH4Cl. 
Inhibition of overall transport with 1 µmol/L NBTI, a concentration that inhibits ENT1 
transport activity [5,11], resulted in a straight first order regression line in the Eadie-Hofstee 265 
plot suggesting a transport mechanism that was likely mediated by hENT1 and hENT2 acting 
in parallel. Indeed, 10 µmol/L NBTI, a concentration inhibiting ENT1 and ENT2 activity 
[5,11], abolished adenosine transport. Since NH4Cl increased the saturable hENT1- and 
hENT2-adenosine transport and Eadie-Hofstee plots were linear, it is unlikely that an acidic 
pHi will induce expression or recruitment of additional membrane transport mechanism(s) in 270 
HUVECs. Interestingly, NH4Cl increased the Km and Vmax values for hENT1- and hENT2-
mediated transport. Thus, activation caused by acidic pHi likely involves a higher availability 
of these membrane transporters at the plasma membrane and changes in their affinity or other 
intrinsic properties. An increase in ENTs activity is suggested by the increase in Vmax/Km seen 
in these cells. Since the relative effect of NH4Cl on Vmax/Km for hENT1-transport was higher 275 
(1/–NH4/+NH4FhENT1 / 1/–NH4/+NH4FhENT1 ~1.2) than for hENT2-transport, confirms that an acidic 
pHi affects the transport capacity of HUVECs.   
In conclusion, HUVECs show adenosine transport mediated by hENT1 and hENT2 
whose activity depends on pHi. An acidic pHi increases the activity of these membrane 
transporters by increasing their Vmax/Km, an effect higher in hENT1 compared with hENT2-280 
adenosine transport. As far as we know, this is the first study addressing that adenosine 
transport via hENT1 and hENT2 is modulated by changes in pHi in HUVECs, and 
complement those showing modulation of nucleoside transport by pHo in this cell type [6]. 
Since the broad biological actions of adenosine in the human body [5], including the 
foetoplacental vasculature [3,5,9,11,12,33-35], changes in the capacity of the endothelium to 285 
remove this nucleoside from the extracellular space is crucial. Our results may have 
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implications in pathological conditions where hENTs-adenosine transport is reduced such as 
in GDM-derived HUVECs [11] or human placental microvascular endothelial cells [12] (see 
Fig. 5). GDM associated with lower Vmax/Km and hENT1 expression in these cell types, and 
pregestational diabetes mellitus courses with acidic pH (pH <7.2) in the umbilical vein blood 290 
[3,14]. Thus, GDM could potentially associate with acidic pHo resulting from increased H+ 
efflux leading to intracellular alkalization as reported in cancer cells [2,3,17]. However, there 
is not available information regarding changes in pHi and hENT1 and hENT2 activity in GDM 
or hyperglycaemia [2,3,34]. Therefore, since hENT1 and hENT2-mediated adenosine 
transport is increased by acidic pHi, looking for a therapeutic approach to restoring a 295 
physiological pHi/pHo ratio, perhaps involving restoration of proper H+ efflux via NHE1 
[2,3], could be beneficial to re-establish GDM-reduced adenosine transport in HUVECs. 
Interestingly, adenosine down-regulates hENT1 expression and activity involving A2B 
adenosine receptors subtype in hPMECs from normal pregnancies [36]). However, whether 
adenosine receptors are involved in pHi modulation in the foetoplacental endothelium is not 300 
yet reported [2,3,34,35].  
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Fig. 1. Effect of NH4Cl pulse on cell pHi and viability. A, Primary cultures of HUVECs 
were preloaded with BCECF-AM and transferred into a spectrofluorometer. Basal pHi 
was stabilized and then cells were exposed (~2 minutes) to a Na+-free solution without 
(0) or with NH4Cl. Cells were then rinsed with NH4Cl-free solution and left in this 
medium. pHi values were estimated from a calibration curve with nigericin (see 435 
Methods). B, Alive cells counted in a haemocytometer under the same conditions as in 
A. C, Cells were preloaded with BCECF-AM and transferred into a spectrofluorometer. 
After basal pHi was stabilized the cells were exposed (2 minutes) to a control solution 
containing 20 mmol/L NH4Cl (+ NH4Cl). Cells were then rinsed with NH4Cl-free 
solution (– NH4Cl) and left in this medium. pHi values were estimated as in A. The 440 
circle indicates the section of the trace shown in D. D, Data for the first 15 seconds after 
removal of NH4Cl as in C. Arrow indicates the time (10 seconds) used for transport 
assays. In A and B, *P<0.05 versus without NH4Cl. Values are mean ± S.E.M. (n = 22). 
In C and D, Data is representative of other 27 different cell cultures. 
445 
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Fig. 2. Effect of NH4Cl on adenosine and hypoxanthine uptake. A, Adenosine (10 µmol/L) 
uptake (10 seconds, 37ºC) was measured in primary cultures of HUVECs non-treated 
(–NH4Cl) or treated (+NH4Cl) with 20 mmol/L NH4Cl as described in Materials and 
Methods. Cells were in the absence (–) or presence (+) of S-(4-nitrobenzyl)-6-thio-
inosine (NBTI), adenosine, hypoxanthine, adenine, and/or 100 µmol/L 5-450 
hydroxytryptamine (+5HT and –5HT). B, Adenosine uptake mediated by hENT1 or 
hENT2 from data in A. C, Hypoxanthine (100 µmol/L) uptake (10 seconds, 37ºC) was 
measured as in A in the absence or presence of NBTI, adenine, or 5HT. D, 
Hypoxanthine uptake mediated by hENT1 or hENT2 from data in C. In A: *P<0.05 
versus all other corresponding values in +5HT or –5HT. †P<0.05 versus 1 µmol/L 455 
NBTI and all other values. In B: *P<0.05 versus values in hENT1 in –NH4Cl. †P<0.05 
versus corresponding hENT2 and hENT1 in +NH4Cl. In C: *P<0.05 versus 
corresponding values in –NH4Cl. †P<0.05 versus corresponding values in the absence 
or 1 µmol/L NBTI. In D: *P<0.05 versus corresponding hENT1. †P<0.05 versus 
corresponding hENT2. Values are mean ± S.E.M. (n = 16-22). 460 
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Fig. 3. pHi dependency of hENT1 and hENT2-mediated adenosine uptake. A, Overall 465 
adenosine (10 µmol/L) uptake (10 seconds, 37ºC) measured in primary cultures of 
HUVECs non-treated (0) or treated with NH4Cl as described in Materials and 
Methods. Uptake was in the absence (Control) or presence of S-(4-nitrobenzyl)-6-thio-
inosine (NBTI). B, Adenosine uptake mediated by hENT1 or hENT2 from data in A. 
C, Adenosine uptake mediated by hENT1 or hENT2 from data in B. The pHi was 470 
estimated from a calibration curve with nigericine (see Materials and Methods). D, 
Representative Western blot for hENT1 and hENT2 in HUVE s at basal pHi (β-actin 
is internal reference). Lanes are two different cell cultures from different umbilical 
cords representative of other five samples from pregnant women. Lower panel: 
densitometry ratios for hENT1/β-actin or hENT2/β-actin normalized to 1 for hENT1. 475 
In A and B: *P<0.05 versus corresponding 0 NH4Cl. In C: *P<0.05 versus pHi 7.2. In 
D: *P<0.04 versus hENT1. Values are mean ± S.E.M. (n = 22). 
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Fig. 4. Effect of NH4Cl on adenosine transport kinetics. A, Overall adenosine uptake (10 480 
seconds, 37ºC) in primary cultures of HUVECs non-treated (Control) or treated with 
NH4Cl as described in Materials and Methods. Transport was in the absence or 
presence of S-(4-nitrobenzyl)-6-thio-inosine (NBTI). B, Saturable adenosine transport 
mediated by hENT1 from data in A. Data was adjusted to a single Michaelis-Menten 
equation to obtain maximal velocity and apparent Michaelis-Menten constant of 485 
adenosine transport at initial rates (lineal uptake up to 10 seconds) (see online 
Supplemental Methods). C, Saturable adenosine transport mediated by hENT2 from 
data in A (data analysed as in B). Lower panels show corresponding Eadie-Hofstee 
plots. Values are mean ± S.E.M. (n = 22). 
 490 
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Fig. 5. Physiological context for pHi-modulated adenosine transport in the human 
foetoplacental endothelium in gestational diabetes mellitus. In human umbilical 
vein endothelial cells from normal pregnancies the level of protons (H+) within the 
cells results in a physiological intracellular pH (pHi). The pHi value (pHi ~7.2 in this 495 
study) is maintained by the function of sodium/H+ exchangers (NHEs). Measurements 
reported in human umbilical vein blood show that extracellular pH (pHo) is slightly 
alkaline (pHo ~7.4). These intracellular and extracellular environmental conditions 
result in physiological extracellular adenosine concentration due to its removal by 
human equilibrative nucleoside transporters 1 (hENT1) and 2 (hENT2). In pathologies 500 
of pregnancy where the metabolism of D-glucose is altered, such as gestational 
diabetes mellitus (GDM), there is a high risk of generating large amounts of H+, which 
are removed via NHEs whose activity is higher (large orange arrow) than in normal 
cells. This phenomenon will result in a potential intracellular alkalization (pHi >7.2) 
and extracellular acidification (pHo ~7.2) [3,14,25] in GDM pregnancies. The latter 505 
could explain the reduced hENT1 expression and activity (dashed orange arrow) 
reported in HUVECs and human microvascular endothelial cells (hPMECs) from this 
disease. Composed from data in this study and [3,11,12,14,25]. 
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Table 1. Kinetic parameters for adenosine transport. 
 
 
Overall transport  
  – NH4Cl + NH4Cl  
 
vi (pmol/µg protein/0.03 seconds) 
    
 Without NBTI 0.052 ± 0.002  0.315 ± 0.007 *  
 1 µmol/L NBTI inhibited fraction 0.007 ± 0.002  0.012 ± 0.002 *  
 10 µmol/L NBTI inhibited fraction nm  nm  
KD (pmol/µg protein/second/(µmol/L))     
 Without NBTI 0.0063 ± 0.002  0.0092 ± 0.003*  
 1 µmol/L NBTI inhibited fraction 0.0052 ± 0.002  0.0051 ± 0.002  
 10 µmol/L NBTI inhibited fraction nm  nm  
 
 
  
 
Saturable transport 
 
 
 
 hENT1  hENT2  
  
– NH4Cl  + NH4Cl  – NH4Cl  + NH4Cl  
         
Vmax (pmol/µg protein/second) 2.1 ± 0.1  12.9 ± 0.9 *  0.6 ± 0.1 *  2.2 ± 0.1 †  
Km (µmol/L) 32 ± 4  121 ± 22 *  49 ± 9  130 ± 21 *†  
Vmax/Km (pmol/µg protein/second/(µmol/L)) 0.066 ± 0.005  0.107 ± 0.005 *  0.012 ± 0.001 *  0.017 ± 0.002 *†  
           
 
 
Relative contributions 
hENT1/2F
–NH4 5.50 ± 0.02 
hENT1/2F+NH4    6.37 ± 0.03 * 
1/–NH4/+NH4FhENT1 1.62 ± 0.02 
1/–NH4/+NH4FhENT2 
   1.41 ± 0.01 ‡ 
Legend for Table 1 in the next page. 
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Legend for Table 1. 589 
 590 
Kinetics for overall (hENT1 + hENT2), hENT1, and hENT2 transport of adenosine (0-500 591 
µmol/L adenosine, 10 seconds, 37°C) was measured in primary cultures of HUVECs non-treated 592 
(– NH4Cl) or treated (+ NH4Cl) with 1 mmol/L NH4Cl (see Methods). The initial velocity (vi) for 593 
10 µmol/L adenosine was estimated for 0.03 seconds from the slope of lineal phase of uptake 594 
adjusted to one phase exponential association equation considering the least squares fit [19]. The 595 
lineal, non-saturable component of adenosine transport (KD) was derived from a Michaelis-596 
Menten hyperbola plus KD (slope of transport • adenosine concentration) (see Methods). The vi 597 
and KD were calculated for overall transport (i.e., in the absence of S-(4-nitrobenzyl)-6-thio-598 
inosine (NBTI) (Without NBTI)) and for the fraction of adenosine transport inhibited by NBTI. 599 
Maximal velocity (Vmax) and the apparent Michaelis-Menten constant (Km) were obtained by 600 
plotting transport data to a single Michaelis-Menten asymptotic equation having removed the KD 601 
component from overall transport [19]. Vmax/Km is maximal transport capacity of adenosine. The 602 
relative contribution (F) of hENT1 versus hENT2 to adenosine transport in cells non-treated 603 
(hENT1/2F
–NH4) or treated (hENT1/2F+NH4) with NH4Cl, and the relative contribution of treating cells 604 
with NH4Cl to hENT1 (1/–NH4/+NH4FhENT1) or hENT2 (1/–NH4/+NH4FhENT2) mediated transport were 605 
calculated from corresponding Vmax/Km values (see Supplementary Methods). *P<0.05 versus 606 
corresponding values for hENT1 in cells non-treated with NH4Cl. †P<0.05 versus corresponding 607 
values for hENT2 in cells non-treated with NH4Cl. ‡P<0.05 versus 1/–NH4/+NH4FhENT1. Values are 608 
means ± S.E.M. (n = 23). nm, not measurable. 609 
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Highlights 
• Acidic pHi increases the overall adenosine transport in foetoplacental endothelium. 
• Acidic pHi increases hENT1 and hENT2 maximal transport capacity. 
• hENT1 activity is more sensitive than hENT2 to intracellular acidification.  
• ENTs activity in human foetoplacental endothelium is regulated by pHi.  
